A Phase 1 Dose Escalation Study of Oral VX-708 in Healthy Participants
Clinical trial NCT05347394 · COMPLETED
Trial details
- NCT number
- NCT05347394
- Sponsor
- Vertex Pharmaceuticals Incorporated
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-08
- Primary completion
- 2023-04-14
- Enrollment
- 100
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.